Document Type

Poster

Presentation Date

5-30-2026

Comments

Presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.

Abstract

Background/Research Objective

Cannabis is increasingly used to manage cancer-related symptoms including pain, sleep disturbance, anxiety, and appetite or gastrointestinal complaints. However, patient responses are highly variable, clinicians report limited confidence in guiding use, and optimal dosing is difficult to predict from baseline characteristics. We evaluated whether an iterative, guided cannabis care model incorporating ongoing patient feedback and care-plan adjustments is associated with improved symptom relief and lower side-effect burden in a real-world oncology population.

Language

English

Included in

Oncology Commons

Share

COinS